254 related articles for article (PubMed ID: 29616326)
21. Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.
Cifaldi L; Locatelli F; Marasco E; Moretta L; Pistoia V
Trends Mol Med; 2017 Dec; 23(12):1156-1175. PubMed ID: 29133133
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of NK cell-mediated lysis of non-small lung cancer cells by nPKC activator, ingenol 3,20 dibenzoate.
Gong C; Yao C; Xu Z; Ni Z; Zhu X; Wang L; Yan X; Zhou W; Zhu S
Mol Immunol; 2017 Mar; 83():23-32. PubMed ID: 28092804
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
[TBL] [Abstract][Full Text] [Related]
24. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
[TBL] [Abstract][Full Text] [Related]
25. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
26. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
27. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.
Tonn T; Becker S; Esser R; Schwabe D; Seifried E
J Hematother Stem Cell Res; 2001 Aug; 10(4):535-44. PubMed ID: 11522236
[TBL] [Abstract][Full Text] [Related]
28. Cytokine regulation of natural killer cell effector functions.
Zwirner NW; Domaica CI
Biofactors; 2010; 36(4):274-88. PubMed ID: 20623510
[TBL] [Abstract][Full Text] [Related]
29. Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma.
Pitchenik AE; Guffee J; Stein-Streilein J
Am Rev Respir Dis; 1987 Dec; 136(6):1327-32. PubMed ID: 3500659
[TBL] [Abstract][Full Text] [Related]
30. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
Jin GH; Hirano T; Murakami M
Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer.
Lin M; Liang SZ; Shi J; Niu LZ; Chen JB; Zhang MJ; Xu KC
Immunol Lett; 2017 Nov; 191():10-15. PubMed ID: 28916277
[TBL] [Abstract][Full Text] [Related]
32. Natural Killer Cells in the Lungs.
Cong J; Wei H
Front Immunol; 2019; 10():1416. PubMed ID: 31293580
[TBL] [Abstract][Full Text] [Related]
33. Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
Cui F; Ji J; Lv H; Qu D; Yu C; Yang Y; Xu Y
J Cancer Res Ther; 2013 Nov; 9 Suppl():S162-8. PubMed ID: 24516054
[TBL] [Abstract][Full Text] [Related]
34. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
[TBL] [Abstract][Full Text] [Related]
35. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with primary lung cancer.
Kim SK; Cho CH; Ahn CM; Jang SH; Lee YH; Kim SK; Chang J; Lee BK; Kim SJ; Youn JK
Yonsei Med J; 1992 Mar; 33(1):41-7. PubMed ID: 1502829
[TBL] [Abstract][Full Text] [Related]
36. Intracellular osteopontin regulates homeostasis and function of natural killer cells.
Leavenworth JW; Verbinnen B; Wang Q; Shen E; Cantor H
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):494-9. PubMed ID: 25550515
[TBL] [Abstract][Full Text] [Related]
37. [Role of NK cells in lung metastasis immunosurveillance].
Kobayashi T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1233-45. PubMed ID: 2658817
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
Gillgrass AE; Chew MV; Krneta T; Ashkar AA
BMC Cancer; 2015 Apr; 15():293. PubMed ID: 25879689
[TBL] [Abstract][Full Text] [Related]
39. Shaping of Natural Killer Cell Antitumor Activity by
Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
Front Immunol; 2017; 8():458. PubMed ID: 28491060
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
Hirschowitz EA; Crystal RG
Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
